COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
A Fendler, EGE de Vries… - Nature Reviews …, 2022 - nature.com
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …
associated mortality than the general population. Owing to this increased risk, patients with …
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study …
D Cohen, SH Krauthammer, I Wolf… - European Journal of …, 2021 - Springer
Purpose Nationwide mass vaccination against Covid-19 started in Israel in late 2020. Soon
we identified on [18 F] FDG PET-CT studies vaccine-associated hypermetabolic …
we identified on [18 F] FDG PET-CT studies vaccine-associated hypermetabolic …
COVID-19 vaccination-related uptake on FDG PET/CT: an emerging dilemma and suggestions for management
LJ McIntosh, AA Bankier… - American Journal of …, 2021 - Am Roentgen Ray Soc
As mass COVID-19 vaccination is underway, radiologists are encountering transient FDG
uptake in normal or enlarged axillary, supraclavicular, and cervical lymph nodes after …
uptake in normal or enlarged axillary, supraclavicular, and cervical lymph nodes after …
Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer
C Villarreal-Garza, BF Vaca-Cartagena… - JAMA …, 2021 - jamanetwork.com
Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With
Breast Cancer | Breast Cancer | JAMA Oncology | JAMA Network [Skip to Navigation] Our …
Breast Cancer | Breast Cancer | JAMA Oncology | JAMA Network [Skip to Navigation] Our …
Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties
CD Lehman, HA D'Alessandro, DP Mendoza… - Journal of the American …, 2021 - Elsevier
Reports are rising of patients with unilateral axillary lymphadenopathy, visible on diverse
imaging examinations, after recent coronavirus disease 2019 vaccination. With less than …
imaging examinations, after recent coronavirus disease 2019 vaccination. With less than …
Lymphadenopathy following COVID-19 vaccination: imaging findings review
Rationale and Objectives Despite all the benefits and effectiveness of the coronavirus
disease 2019 (COVID-19) vaccines mentioned in recent clinical trials, some post …
disease 2019 (COVID-19) vaccines mentioned in recent clinical trials, some post …
[HTML][HTML] Rapid progression of angioimmunoblastic T cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report
S Goldman, D Bron, T Tousseyn, I Vierasu… - Frontiers in …, 2021 - frontiersin.org
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is
important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on …
important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on …
Axillary adenopathy after COVID-19 vaccine: no reason to delay screening mammogram
S Wolfson, E Kim, A Plaunova, R Bukhman… - Radiology, 2022 - pubs.rsna.org
Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram |
Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All …
Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu Home Journals All …
Prevalence of increased FDG PET/CT axillary lymph node uptake beyond 6 weeks after mRNA COVID-19 vaccination
Y Eshet, N Tau, Y Alhoubani, N Kanana… - Radiology, 2021 - pubs.rsna.org
Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after
mRNA COVID-19 Vaccination | Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu …
mRNA COVID-19 Vaccination | Radiology RSNA "skipMainNavigation" closeDrawerMenuopenDrawerMenu …